Form D · Other Health Care
Veravas, Inc.
Austin, TX · CIK 0001789835
Offering snapshot reported Apr 1, 2024 · SEC filing
- Reported sold
- $20.6M Offering amount: $26.4M
- Investors reported
- 138 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 15, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 1, 2024 | Initial | $20,579,251 | No comparison | 138 | SEC filing |
| Mar 29, 2023 | Initial | $775,000 | No comparison | 12 | SEC filing |
| Oct 1, 2019 | Initial | $375,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity, Debt, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-509194
Includes conversion of debt into equity
Source: Form D, filed Apr 1, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Frederick Allen Baumbach | Executive |
| Jeremy Coote | Director |
| John Forrest | Director, Executive, Promoter |
| Will Kiker | Director |
| James Kyle | Director |
| Carroll E. Streetman, Jr. | Executive |
| Luc Vanhal | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
111 Congress Avenue Suite 500
Austin, TX, 78701
Austin, TX, 78701